Literature DB >> 24711748

Some amino acids levels: glutamine,glutamate, and homocysteine, in plasma of children with chronic kidney disease.

Fatina I Fadel1, Manal F Elshamaa2, Rascha G Essam1, Eman A Elghoroury3, Gamila S M El-Saeed4, Safinaz E El-Toukhy4, Mona Hamed Ibrahim3.   

Abstract

BACKGROUND: The high prevalence of protein-energy malnutrition is a critical issue for patients with chronic kidney disease (CKD). Serum albumin is the most commonly used nutritional marker. Another index is plasma amino acid (AA) profile. Of these, the plasma levels of glutamine, glutamate and homocysteine, correlate well with nutritional status. We measured some plasma AAs in children with different stages CKD to provide information in monitoring the therapeutic strategy, particularly in AA supplementary therapy or protein restriction.
METHODS: Three amino acids were evaluated along with albumin and high sensitivity C-reactive protein (hs-CRP) in 30 patients with advanced CKD stages 4 and 5. They were divided into two groups undergoing conservative treatment (CT) (n=15) or hemodialysis (HD) (n=15). An additional group of patients with nephrotic syndrome [CKD stage 2] was also studied to assess the alterations of plasma free amino acids with the early stage of CKD. Another 30 age- and sex-matched healthy children served as controls.
RESULTS: A significant increase in plasma concentration of amino acid glutamine was observed in children with advanced CKD stages 4 and 5 when compared with controls (P=0.02).Plasma glutamine level was significantly higher in ESRD children on HD than in children with nephrotic syndrome (P=0.02). We did not find a significant difference between HD children and CT children as regard to glutamine level. Notable differences were in the plasma homocysteine level detected in the CKD groups patients, which was greater than that in controls (P=0.0001). Plasma homocysteine level was significantly higher in children on HD than in children with nephrotic syndrome (P=0.01). A significant differences was observed in hs-CRP levels between the CKD groups and the controls (P=0.04). Albumin levels were lower in CKD groups than in controls (p=0.01). Glutamine showed significant positive correlations with blood urea level (r=0.84, P=0.002) and blood ammonia level (r=0.72, P=0.0001). On multiple linear regression, urea was the only variable independently associated with an elevated plasma glutamine level (Beta=0.77, P=0.02).
CONCLUSION: This study indicates that the advanced stages of CKD are associated with increased plasma concentrations of glutamine and homocysteine. Glutamine retained in the plasma of children with CRF, possibly producing higher levels of the waste products (urea and NH3). Dialysis alone is insufficient to redress completely the abnormalities in AA metabolism in ESRD children. Careful consideration of dialysis and dietary measures are necessary.

Entities:  

Keywords:  Children; ESRD; Glutamate; Glutamine; HD; Homocysteine; NS

Year:  2014        PMID: 24711748      PMCID: PMC3976446     

Source DB:  PubMed          Journal:  Int J Biomed Sci        ISSN: 1550-9702


  44 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency.

Authors:  Minh-Uyen Trinh; Jennifer Blake; J Rodney Harrison; Rosemarie Gerace; Enzo Ranieri; Janice M Fletcher; David W Johnson
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

Review 3.  Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients?

Authors:  Michel Aparicio; Vincenzo Bellizzi; Philippe Chauveau; Adamasco Cupisti; Tevfik Ecder; Denis Fouque; Liliana Garneata; Shanyan Lin; William Mitch; Vladimir Teplan; Xueqing Yu; Gabor Zakar
Journal:  Semin Dial       Date:  2013-09-09       Impact factor: 3.455

4.  Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  Chih-Kuang Chuang; Shuan-Pei Lin; Han-Hsiang Chen; Yi-Chou Chen; Tuan-Jen Wang; Wen-Hsiang Shieh; Chih-Jen Wu
Journal:  Clin Chim Acta       Date:  2005-08-08       Impact factor: 3.786

5.  Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients.

Authors:  M E Suliman; J C Divino Filho; P Bàràny; B Anderstam; B Lindholm; J Bergström
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

6.  Effect of nephrotic syndrome on homocysteine metabolism.

Authors:  Mohammad A Aminzadeh; Pavan Gollapudi; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2010-09-08       Impact factor: 5.992

7.  Early changes in bioelectrical estimates of body composition in chronic kidney disease.

Authors:  Vincenzo Bellizzi; Luca Scalfi; Vincenzo Terracciano; Luca De Nicola; Roberto Minutolo; Maurizio Marra; Bruna Guida; Bruno Cianciaruso; Giuseppe Conte; Biagio R Di Iorio
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

8.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.

Authors:  R Kinscherf; V Hack; T Fischbach; B Friedmann; C Weiss; L Edler; P Bärtsch; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

9.  The effects of peritoneal dialysis on blood glutamate levels: implementation for neuroprotection.

Authors:  Boris Rogachev; Svetlana Tsesis; Benjamin F Gruenbaum; Shaun E Gruenbaum; Matthew Boyko; Moti Klein; Yoram Shapira; Marina Vorobiev; Alexander Zlotnik
Journal:  J Neurosurg Anesthesiol       Date:  2013-07       Impact factor: 3.956

10.  Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Authors:  Jörg C Schefold; Jan-Philip Zeden; Christina Fotopoulou; Stephan von Haehling; Rene Pschowski; Dietrich Hasper; Hans-Dieter Volk; Christine Schuett; Petra Reinke
Journal:  Nephrol Dial Transplant       Date:  2009-01-20       Impact factor: 5.992

View more
  4 in total

1.  Development of Optical Biosensor for the Detection of Glutamine in Human Biofluids Using Merocyanine Dye.

Authors:  Vijayakumar Sathya; Appadurai Deepa; Lakshmi Kandhan Sangeetha; Venkatesan Srinivasadesikan; Shyi-Long Lee; Vediappen Padmini
Journal:  J Fluoresc       Date:  2022-04-14       Impact factor: 2.525

2.  Recurrent white thrombi formation in hemodialysis tubing: a case report.

Authors:  Kiran P Sathe; Wee-Song Yeo; Isaac Desheng Liu; Sudha Ekambaram; Mohammed Azar; Hui-Kim Yap; Kar-Hui Ng
Journal:  BMC Nephrol       Date:  2015-01-15       Impact factor: 2.388

3.  Metabolomic Profiling in Individuals with a Failing Kidney Allograft.

Authors:  Roberto Bassi; Monika A Niewczas; Luigi Biancone; Stefania Bussolino; Sai Merugumala; Sara Tezza; Francesca D'Addio; Moufida Ben Nasr; Alessandro Valderrama-Vasquez; Vera Usuelli; Valentina De Zan; Basset El Essawy; Massimo Venturini; Antonio Secchi; Francesco De Cobelli; Alexander Lin; Anil Chandraker; Paolo Fiorina
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

4.  Essential and Non-Essential Amino Acids in Dogs at Different Stages of Chronic Kidney Disease.

Authors:  Ilaria Lippi; Francesca Perondi; Alessio Pierini; Francesco Bartoli; Eleonora Gori; Chiara Mariti; Veronica Marchetti
Journal:  Vet Sci       Date:  2022-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.